Veterinary CRO Market to Reach $1.33 Bn at 8.1% CAGR Globally, by 2026
Rise in ownership of companion animals, increase animal health expenditure, & surge in prevalence of various diseases among companion animal have boosted growth
PUNE, MAHARASHTRA, INDIA, October 6, 2020 /EINPresswire.com/ -- The demand of veterinary CRO market is on a rise owing to surge in awareness related to animal health across the globe. Furthermore, surge in animal healthcare expenditure worldwide is another major factor that fuels the growth of veterinary CRO market."Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026". According to the report, the global veterinary CRO industry was pegged at $714 million in 2018, and is projected to $1.33 billion by 2026, registering a CAGR 8.1% from 2019 to 2026.
Download Free Sample Report with Detail COVID-19 Impact Analysis@ https://www.alliedmarketresearch.com/request-sample/6265
Veterinary CRO Market Competitive Analysis:-
Leading market players Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd, VetPharm, Inc., and VETSPIN SRL, among others provided in this report. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.
Covid-19 Impact on the Global Veterinary CRO Market:-
Veterinary CRO Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly.
Clinical trials segment dominated the market:-
The clinical trials segment held the largest share in 2018, contributing to nearly one-third of the market, owing to presence of stringent government regulations that support clinical trials of veterinary drugs. Moreover, the segment is expected to portray the fastest CAGR of 8.9% during the forecast period.
Neurology segment to manifest fastest growth through 2026:-
The neurology segment is anticipated to register the fastest CAGR of 9.0% during the study period, owing to surge in awareness related to early diagnosis of neurology disorders in companion animals for better treatment. However, the infectious diseases segment held the largest share in 2018, accounting for one-fifth and is expected to maintain its dominance throughout the study period.
North America held the lion's share:-
The market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to rise in ownership of companion animals and surge in animal healthcare expenditure in the region. However, the market across Asia-Pacific is expected to manifest the fastest CAGR of 9.4% from 2019 to 2026, owing to surge in awareness related to use of awareness among individuals related to treatment and early diagnosis of diseases in companion animals.
Inquiry For More Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/6265
About Us:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
Shadab Pathan
Allied Market Research
+1 800-792-5285
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.